Business
Why the Genetic Signatures (ASX:GSS) share price is edging higher
The Genetic Signatures Ltd (ASX: GSS) share price is edging higher today. This comes after the company announced that it received CE-IVD registration for its 3base EasyScreen sexually transmitted infection (STI) Genital Pathogen Detection Kit.
CE-IVD refers to an approved CE Marking from the European Union for an in vitro diagnostic (IVD) device. This allows the product to be commercially sold within Europe.
What’s driving the Genetic Signatures share price higher
The Genetic Signatures share price is back positive territory as investors jump on the company’s latest news. Originally, the company’s shares were sliding lower on the back of overall weak market sentiment.
According to its release, Genetic Signatures advised its…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Noosa News18 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News23 hours agoEric Bana Is Back in Murder-Mystery Mode (and in Scenic Surroundings) in the Trailer for New Netflix Series ‘Untamed’
-
General21 hours agoInflation hope as RBA decision leaves many disappointed